| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |